What do we do:
Dr. Agustín Ruiz, Research director
"The main objective of our genomic research group is to understand the causes of Alzheimer's disease and other dementias by integrating genetic, transcriptomic and proteomic data."GScholar
GR@ACE - Genomic Research at Fundació ACE
Obra Social la Caixa, Grifols, Instituto de Salud Carlos III & Fundación ACE
The GR@ACE project is a human genetics study aiming to discover new genes that cause Alzheimer's and use this information to propose new treatments to face the disease.
EXIT - Exosomes Isolation Tool with nanofluidic concentration Device
EuroNanoMed III & Instituto de Salud Carlos III
This research project uses technological advances in the field of nanotechnology and the separation of nanoparticles for the early clinical diagnosis of Alzheimer's disease.
ADAPTED - Alzheimer’s Disease Apolipoprotein Pathology for Treatment Elucidation and Development
European Comission (H2020-JTI-IMI2-2015-05)
ADAPTED is a project that investigates the biological mechanisms through which the presence of the APOE gene increases the risk of developing Alzheimer's.
Estudio de variantes raras en genes asociados a Enfermedad de Alzheimer en la población española
Instituto de Salud Carlos III
This project wants to study in depth and detect rare genetic variants associated with Alzheimer's. This is the first genomic study conducted in our country to address this issue specifically in Alzheimer's disease.